Series date: 
01/01/2024 - 12:00am CST to 12/31/2024 - 11:45pm CST

Course Director:

Kristine Hoelle, MSN, RN, CPHON, CPN, Nursing Professional Development Specialist, Pediatric Hematology/Oncology, Advocate Children's Hospital - Oak Lawn

Contact: Kristine.Hoelle@aah.org or 41-4227

Program Overview:

This is an independent study for pediatric nurses that care for oncology hematology patients that provides topics that will increase knowledge and awareness of this population. 


Overall Objectives:

  1. This is an independent study for pediatric nurses that care for oncology hematology patients that provides topics that will increase knowledge and awareness of this population. 

Target Audience:  
This activity is designed for Pediatric hematology oncology nurses.

 

Accreditation Statement
In support of improving patient care, Advocate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Statement(s)

American Nurses Credentialing Center (ANCC) 
Advocate Health designates this enduring activity for a maximum of 1.2 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity. 

 

Series location: 
online
United States

Sessions

Session Date
Peds Hem/Onc Independent Study 2024: January: Measuring Burnout in Pediatric Oncology Staff: Should We Be Using the Maslach Burnout Inventory? 01/01/2024 - 12:00am CST to 01/31/2024 - 11:45pm CST
Peds Hem/Onc Independent Study 2024: February: Experiences of Parenting a Child Receiving Dexamethasone During Maintenance Chemotherapy for ALL 02/01/2024 - 12:00am CST to 02/29/2024 - 11:45pm CST
Peds Hem/Onc Independent Study 2024: March: Oncology Clinicians’ Perspectives on Online Patient Portal Use in Pediatric and Adolescent Cancer 03/01/2024 - 12:00am CST to 03/31/2024 - 11:45pm CDT
Peds Hem/Onc Independent Study 2024: April: We Are Done! Now What? Exploring End of Treatment Needs of Childhood Cancer Survivors and Their Parents 04/01/2024 - 12:00am CDT to 04/30/2024 - 11:45pm CDT
Peds Hem/Onc Independent Study 2024: May: Infertility and Identity: A Closer Look Into Experiences of Emerging Young Adult Childhood Cancer Survivors 05/01/2024 - 12:00am CDT to 05/31/2024 - 11:45pm CDT
Peds Hem/Onc Independent Study 2024: June: Impact of Propofol Exposure on Neurocognitive Outcomes in Children With High-Risk B ALL 06/01/2024 - 12:00am CDT to 06/30/2024 - 11:45pm CDT
Peds Hem/Onc Independent Study 2024: July: Experiences and Preferences of Truth-telling in Families of Children with Cancer: A Phenomenological Study 07/01/2024 - 12:00am CDT to 07/31/2024 - 11:45pm CDT
Peds Hem/Onc Independent Study 2024: August: Guidelines for Outpatient Administration of Naxitamab: Experience from Atrium Health Levine Children's Hospital 08/01/2024 - 12:00am CDT to 08/31/2024 - 11:45pm CDT
Peds Hem/Onc Independent Study 2024: September: Virtual Reality for Pediatric Oncology Port-A-Cath Access: A Pilot Effectiveness Study 09/01/2024 - 12:00am CDT to 09/30/2024 - 11:45pm CDT
Peds Hem/Onc Independent Study 2024: October: Blinatumomab for First-Line Treatment of Children and Young Persons With B-ALL 10/01/2024 - 12:00am CDT to 10/31/2024 - 11:45pm CDT

Pages